PT-141 10mg
€61.00
PT-141 (Bremelanotide) – The Premier Melanocortin Peptide for Sexual Function, Libido & Desire Research
For researchers and clinicians studying sexual dysfunction, libido enhancement, and melanocortin receptor pharmacology, PT-141 (Bremelanotide) represents the most scientifically validated and mechanistically unique sexual function research peptide available. As the only known compound that activates sexual desire and arousal through direct central nervous system melanocortin receptor signaling — rather than through vascular mechanisms like PDE5 inhibitors — PT-141 addresses the neurobiological roots of sexual dysfunction in both men and women with an approach that no pharmaceutical alternative can replicate. Buy PT 141 Online or Find genuine PT-141 peptide for sale now at Collagenpeptideseu — your verified, trusted source for pharmaceutical-grade research peptides.
What Is PT-141 (Bremelanotide)?
PT-141, also known by its INN designation Bremelanotide, is a synthetic cyclic heptapeptide and non-selective melanocortin receptor agonist — derived from the tanning peptide Melanotan II (MT-2) by removing the C-terminal amide group and converting the compound to a cyclic structure. Originally investigated as a potential tanning agent in the same research program that produced Melanotan I and II, PT-141 was discovered to produce pronounced sexual arousal effects in human research subjects — redirecting its development entirely toward sexual dysfunction research.
PT-141 exerts its remarkable effects by activating melanocortin receptors MC3R and MC4R in the central nervous system — particularly in the hypothalamus and limbic system, where these receptors regulate sexual motivation, arousal, and desire at the neurobiological level. This central mechanism is what makes PT-141 online research so uniquely valuable — it addresses the brain’s sexual desire circuitry directly, rather than simply increasing blood flow to genital tissue as PDE5 inhibitors do.
PT-141 received FDA approval in 2019 as Vyleesi (Palatin Technologies) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women — becoming the first and only FDA-approved melanocortin-based sexual dysfunction therapy in history, and providing PT-141 with an exceptional clinical validation profile.
Is PT-141 Better Than Viagra? – The Critical Comparison
The question is PT-141 better than Viagra is one of the most frequently asked in sexual function research — and the answer depends entirely on the underlying mechanism being targeted:
| Feature | PT-141 (Bremelanotide) | Viagra (Sildenafil) |
|---|---|---|
| Mechanism | Central melanocortin (MC3R/MC4R) | PDE5 inhibition (vascular) |
| Target | Brain desire/arousal circuits | Penile vasodilation |
| Works For Women | Yes — FDA approved for HSDD | Minimal documented efficacy |
| Requires Arousal | No — directly activates desire | Yes — requires sexual stimulation |
| Cardiovascular Risk | Minimal | Contraindicated with nitrates |
| Onset | 45 minutes–1 hour | 30–60 minutes |
| Duration | Up to 12 hours | 4–6 hours |
| Psychological Component | Addresses desire directly | Addresses physical response only |
| Approval | FDA approved (Vyleesi) | FDA approved (Viagra) |
The verdict on PT-141 vs Viagra: PT-141 and PDE5 inhibitors are not alternatives — they are complementary compounds addressing different aspects of sexual dysfunction. PT-141 addresses the neurobiological desire and arousal component while Viagra addresses the vascular physical response component. For researchers studying psychological or CNS-mediated sexual dysfunction — particularly in women or in cases where PDE5 inhibitors have failed — PT-141 provides a uniquely valuable research tool that Viagra cannot replicate.
Kisspeptin vs PT-141 – Two Approaches to Sexual Function Research
The Kisspeptin vs PT-141 comparison highlights two distinct neuropeptide approaches to sexual function enhancement:
| Feature | PT-141 | Kisspeptin |
|---|---|---|
| Receptor Target | MC3R/MC4R (melanocortin) | KISS1R (kisspeptin receptor) |
| Primary Effect | Direct arousal/desire activation | GnRH stimulation → LH/FSH/sex hormones |
| Onset Speed | Rapid (45–60 minutes) | Slower (hormonal cascade) |
| Sexual Desire | Direct CNS activation | Indirect (via testosterone/estrogen) |
| FDA Status | Approved (Vyleesi) | Research use |
| Duration | Up to 12 hours | Hormonal (longer-acting) |
| Best For | Acute desire/arousal research | Hormonal axis and fertility research |
The verdict: PT-141 and Kisspeptin target completely different mechanisms in the sexual function and reproductive biology research space — PT-141 for direct CNS desire activation and Kisspeptin for hormonal axis modulation. Advanced reproductive research protocols may incorporate both for comprehensive coverage.
Key Research Benefits of PT-141
Buy PT-141 research consistently documents outstanding outcomes across both male and female sexual function applications:
For Male Sexual Function Research:
- Enhanced sexual desire and libido — direct MC3R/MC4R activation in hypothalamic desire circuits
- Improved erectile function — central neurological pro-erectile signaling complementary to vascular mechanisms
- Increased sexual motivation — documented improvements in sexual interest and initiation
- Efficacy in PDE5 non-responders — documented sexual response in subjects who do not respond to Viagra or Cialis
For Female Sexual Function Research:
- FDA-approved HSDD treatment — the only approved pharmacotherapy for hypoactive sexual desire disorder in premenopausal women
- Enhanced arousal and desire — direct CNS activation of female sexual desire circuits
- Improved sexual satisfaction outcomes — documented in multiple clinical trials supporting FDA approval
- Non-hormonal mechanism — suitable for women where hormonal therapies are contraindicated
General Research Benefits:
- Long duration of action — up to 12-hour research window from a single subcutaneous injection
- Central nervous system target — unique insights into melanocortin receptor regulation of sexual behavior
- Complementary to PDE5 inhibitors — covers the psychological/desire component that Viagra cannot address
- Well-characterized safety profile — extensive clinical trial data supporting FDA approval
PT-141 Dosage – Research Protocol Guide
- Standard research dose: 1.75mg subcutaneous injection (FDA-approved clinical dose)
- Research dose range: 1–2mg per administration depending on research parameters
- Administration: Subcutaneous injection — abdomen preferred
- Onset: Sexual arousal effects typically observed 45–60 minutes post-injection
- Duration: Effects documented for up to 12 hours
- Frequency: As-needed administration protocol; not designed for daily use
- Reconstitution: Mix with bacteriostatic water; store at 2–8°C; use within 30 days
- Important research note: Blood pressure monitoring recommended during initial administrations — transient blood pressure elevation is a documented effect
PT-141 Near Me vs Ordering Online
For researchers and clinicians searching for PT-141 near me or PT-141 peptide for men near me at local wellness or sexual health clinics, ordering pharmaceutical-grade PT-141 directly from Collagenpeptideseu offers compelling advantages:
- Significantly lower cost — clinic-administered PT-141 protocols typically range $50–$200 per dose; Collagenpeptideseu delivers pharmaceutical-grade PT-141 at a fraction of per-dose clinic pricing
- No appointment barriers — research procurement without scheduling constraints
- Superior quality documentation — independently batch-tested with certificate of analysis
- Discreet door-to-door delivery — tamper-proof packaging delivered directly worldwide
Why Buy PT-141 from Collagenpeptideseu
When you buy PT-141 from Collagenpeptideseu, you receive:
- ✔ Pharmaceutical-grade PT-141 — verified cyclic heptapeptide structure and MC3R/MC4R binding activity confirmed
- ✔ Third-party batch testing — independent purity, identity, and concentration verification
- ✔ Proper lyophilization — maximum peptide stability and extended shelf life
- ✔ Competitive global pricing — best value for FDA-equivalent sexual function research peptide
- ✔ Discreet, tamper-proof packaging — protecting peptide integrity throughout transit
- ✔ Real-time shipment tracking — full order visibility from purchase to delivery
- ✔ Expert multilingual support — English, German, French, Spanish, and Portuguese
Order PT-141 Today
Whether you’re researching melanocortin receptor pharmacology, central nervous system sexual function circuits, hypoactive sexual desire disorder, female sexual dysfunction, or the comprehensive neurobiology of sexual arousal and desire, PT-141 (Bremelanotide) delivers the most clinically validated and mechanistically unique sexual function research peptide available in 2025.
Order now at Collagenpeptideseu — the most trusted source for pharmaceutical-grade PT-141 worldwide.
This product is intended for research purposes only. Always consult a licensed healthcare professional before beginning any PT-141 or melanocortin receptor research protocol.
| Please select a size | 10mg (10 vials), 50mg (10 vials) |
|---|
The power of makeup is undeniable; our favorite products help us create the beauty looks we love, enhance our favorite features, and encapsulate our individual definitions of beauty. The best makeup routines help the modern woman boost her confidence and face the world head on—no matter what the day has in store.
What Is the Correct Order of Makeup?
We know you’ve watched countless makeup tutorials online, seen your favorite celebrities get their makeup done with their favorite cosmetics, and you may have even done yours alongside them. But, there are never too many helpful tools and guides to aid you along on your makeup journey!
That is where we come in with our guide that gives you the steps to apply makeup. Before we give you the 4-1-1 on steps to apply makeup, we want to let you know there really is no set-in-stone correct order. When it comes to following makeup steps in order, you want to remember that you should do what works best for your skill level, your skin.
